Orhan Betül, Malbora Barış, Akça Bayar Sezin, Avcı Zekai, Alioğlu Bülent, Özbek Namık
Başkent University Faculty of Medicine, Department of Pediatrics, Ankara, Turkey.
Başkent University Faculty of Medicine, Department of Pediatric Hematology, Ankara, Turkey.
Turk J Ophthalmol. 2016 Apr;46(2):62-67. doi: 10.4274/tjo.03880. Epub 2016 Apr 5.
Ophthalmologic disease in patients with acute leukemia occurs due to primary leukemic infiltration (involvement), or secondary to the disease and its treatment. In recent years the life expectancy of acute leukemia patients has increased with the advent of modern therapies. The present study aimed to determine the incidence of ocular manifestations in children with acute leukemia.
The study included 120 patients diagnosed with acute leukemia at Başkent University Hospital, Pediatric Hematology Department between 1995 and 2010. All the patients were examined by an ophthalmologist via direct and indirect ophthalmoscopy.
Among the patients, 83 (69.2%) were diagnosed with acute lymphoblastic leukemia, 35 (29.1%) with acute myeloblastic leukemia, and 2 (1.7%) with mixed-lineage leukemia. In all, 58 ophthalmic manifestations were noted in 41 patients (34.2%). In our patients, 12 ophthalmologic involvements were present at admission and 46 ocular findings occurred during follow-up. The incidence of these manifestations increased with age.
Ophthalmologic manifestations were not correlated with gender, hematological parameters at disease onset, type of leukemia, or the frequency of relapse and survival. To more clearly determine the effect of ophthalmologic manifestations on the prognosis of leukemia, larger scale and multi-center studies are needed.
急性白血病患者的眼科疾病是由原发性白血病浸润(累及)引起的,或是疾病及其治疗的继发性结果。近年来,随着现代疗法的出现,急性白血病患者的预期寿命有所增加。本研究旨在确定急性白血病患儿眼部表现的发生率。
该研究纳入了1995年至2010年间在巴斯肯特大学医院儿科血液科诊断为急性白血病的120例患者。所有患者均由眼科医生通过直接和间接检眼镜进行检查。
在这些患者中,83例(69.2%)被诊断为急性淋巴细胞白血病,35例(29.1%)为急性髓细胞白血病,2例(1.7%)为混合谱系白血病。共有41例患者(34.2%)出现了58种眼部表现。在我们的患者中,12例眼部受累在入院时就已存在,46例眼部发现出现在随访期间。这些表现的发生率随年龄增加而升高。
眼部表现与性别、疾病发作时的血液学参数、白血病类型或复发频率及生存率无关。为了更清楚地确定眼部表现对白血病预后的影响,需要进行更大规模的多中心研究。